Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Apr 27, 2021 11:07am
126 Views
Post# 33074209

RE:WTF?

RE:WTF?Our little Stockbonds458 would like TLT to invent data, embelish the data, because he's invested!

"I truly believe in the technology" ... lollll

That's an emotional statement.  I assume that if you're invested, that was because you wanted to make money, like anybody else.  But whether you want to make money or not, science doesn't care.  There is no link.  And TLT want this to work more than you and me.  

Clinical trials are there to collect data, based on predetermined endpoints and inclusion/exclusion criterias.  Science measures.  It's not emotional.  It's based on facts.  Not on whether one is invested in a stock.

The last thing you want is management to tweak data.  Because that would mean that they would make you believe of something positive when it shouldn't.  FDA won't tweak data when it comes to approval, despite all the plot theorists that we read here (i.e. those Trump HCQ cons and anti-vaccine cons).

Some finally realize the purpose of a Ph. 2.  It goes much further than just a Ph. 1.  More data always bring more insights, good or bad.   And a Ph. 3 (not required here) would push the envelope even further (just like we see with vaccines, etc ...) as it would have a larger sample.  Just common sense.


"will just let this garbage quarterly pass like thIs mornings bathroom trip." ... lolll these numbers won't change tomorrow.  They are only part of a sample that will enlarge as more patients are being treated.  Then, at one point, no more data will be included and stats will be calculated to confirm/infirm a statistical efficacy.

__________________________

stocksnbonds458 - (4/27/2021 9:07:27 AM)
WTF?
They did it again, another confusing quarterly report that requires the input of knowledgeable people on this board to interpret. This time however they include a real zinger--a death!! Are they intentionally trying to drive down the share price for goodness sake?? Most people reading this report will only see "a death & 33% CR," the rest is just blah blah blah. Totally useless information here that was not required to be released. Amazingly incompetent PR team, they should be waiting until the next batch of results DOES improve the average significantly. I am one pissed long!!! I truly believe in the technology and will just let this garbage quarterly pass like thIs mornings bathroom trip.
<< Previous
Bullboard Posts
Next >>